Biopol Chemicals Ipo
Biopol Chemicals IPO Review & Key Points
Review: Neutral
IPO Lead Managers aka Merchant Bankers
Smart Horizon Capital Advisors Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,400 | ₹2,59,200 |
| Retail Maximum | 2 | 2,400 | ₹2,59,200 |
| S-HNI Minimum | 3 | 3,600 | ₹3,88,800 |
| S-HNI Maximum | 7 | 8,400 | ₹9,07,200 |
| B-HNI Minimum | 8 | 9,600 | ₹10,36,800 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 6,86,400 Shares | 23.71% |
| NII Shares Offered | 10,94,400 Shares | 37.81% |
| Retail Shares Offered | 9,62,400 Shares | 33.25% |
| IPO Open Date: | February 6, 2026 |
| IPO Close Date: | February 10, 2026 |
| Basis of Allotment: | February 11, 2026 |
| Refunds: | February 12, 2026 |
| Credit to Demat Account: | February 12, 2026 |
| IPO Listing Date: | February 13, 2026 |
| IPO Bidding Cut-off Time: | February 10, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 79,11,000 | -% |
| Promoter Holding Post Issue | 1,08,05,400 | -% |
| Purpose | Crores |
| Acquisition of industrial land | ₹12.26 |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | ₹11.10 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2024 | ₹17.43 | ₹15.72 | ₹2.96 | ₹17.56 |
| 2025 | ₹49.15 | ₹43.35 | ₹4.33 | ₹31.48 |
| Dec 2025 | ₹48.97 | ₹40.89 | ₹6.00 | ₹48.88 |
| KPI | Values |
| ROE: | 38.10% |
| ROCE: | 30.57% |
| EBITDA Margin: | 13.30% |
| PAT Margin: | 8.81% |
| Debt to equity ratio: | 0.57 |
| Earning Per Share (EPS): | ₹5.47 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 32.00% |
| Net Asset Value (NAV): | ₹17.10 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Rossari Biotech Limited | 24.63 | 20.93 | 15.62% | 194.56 | – Cr. |
| Fineotex Chemical Limited | 9.44 | 2.30 | 19.31% | 54.93 | – Cr. |
| Indian Emulsifiers Limited | 10.88 | 7.19 | 20.01% | 91.04 | – Cr. |
| IPO Open Date | February 6, 2026 |
| IPO Close Date | February 10, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹102 to ₹108 Per Share |
| Issue Size | Approx ₹31.26 Crores |
| Fresh Issue | Approx ₹31.26 Crores |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |